The paradigm of G protein receptor transactivation: A mechanistic definition and novel example

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 709-714

  Little, Peter J ^a,b,c   Burch, Micah L ^b,c   Al aryahi, Sefaa ^a   Zheng, Wenhua ^d  

^a RMIT UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Definition; G protein coupled receptors; Protein kinase receptors; Transactivation

Indexed keywords

ENDOTHELIN; G PROTEIN COUPLED RECEPTOR; MEMBRANE RECEPTOR; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE RECEPTOR; SMAD2 PROTEIN; THROMBIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TYROSINE KINASE GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; HUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SHORT SURVEY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; PHOSPHORYLATION; RECEPTORS, G-PROTEIN-COUPLED; TRANSCRIPTIONAL ACTIVATION;

EID: 79955160801     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.75     Document Type: Short Survey

References (43)

1. Dupree, C.S. (2010) Primary prevention of heart failure: an update. Curr. Opin. Cardiol. 22, 478-483.
2. Schieppati, A. and Remuzzi, G. (2004) Fighting renal diseases in poor countries: building a global fund with the help of the pharmaceutical industry. J. Am. Soc. Nephrol. 15, 704-707. (Pubitemid 38294800)
3. Smith, N.J. and Luttrell, L.M. (2006) Signal switching, crosstalk, and arrestin scaffolds: novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension 48, 173-179. (Pubitemid 44309804)
4. Lefkowitz, R.J. (2007) Seven transmembrane receptors: a brief personal retrospective. Biochim. Biophys. Acta 1768, 748-755.
5. Lefkowitz, R.J. (2007) Seven transmembrane receptors: something old, something new. Acta Physiol. (Oxf.) 190, 9-19.
6. Ferguson, S.S., Barak, L.S., Zhang, J., and Caron, M.G. (1996) G-protein-coupled receptor regulation: role of Gprotein- coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74, 1095-1110. (Pubitemid 27047505)
7. Daub, H., Weiss, F.U., Wallasch, C., and Ullrich, A. (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557-560. (Pubitemid 26049585)
8. Daub, H., Wallasch, C., Lankenau, A., Herrlich, A., and Ullrich, A. (1997) Signal characteristics of G proteintransactivated EGF receptor. EMBO J. 16, 7032-7044. (Pubitemid 27520803)
9. Gerthoffer, W.T. (2005) Signal-transduction pathways that regulate visceral smooth muscle function. III. Coupling of muscarinic receptors to signaling kinases and effector proteins in gastrointestinal smooth muscles. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G849-853.
10. Almendro, V., Garcia-Recio, S., and Gascon, P. (2010) Tyrosine kinase receptor transactivation associated to G protein-coupled receptors. Curr. Drug Targets 11, 1169-1180.
11. Lee, C.H., Poburko, D., Sahota, P., Sandhu, J., Ruehlmann, D.O., and van Breemen, C. (2001) The mechanism of phenylephrine-mediated [Ca(2+)](i) oscillations underlying tonic contraction in the rabbit inferior vena cava. J. Physiol. 534, 641-650. (Pubitemid 32700864)
12. Gorlach, C., Benyo, Z., and Wahl, M. (1998) Endothelin-1-induced contraction in cerebral vessels mediated by phospholipase C/protein kinase C cascade. Kidney Int. Suppl. 67, S224-225.
13. Griendling, K.K., Tsuda, T., Berk, B.C., and Alexander, R.W. (1989) Angiotensin II stimulation of vascular smooth muscle cells. Secondary signalling mechanisms. Am. J. Hypertens. 2, 659-665. (Pubitemid 19202876)
14. Andresen, B.T., Linnoila, J.J., Jackson, E.K., and Romero, G.G. (2003) Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells. Hypertension 41, 781-786. (Pubitemid 36314591)
15. Saito, Y. and Berk, B.C. (2001) Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J. Mol. Cell. Cardiol. 33, 3-7. (Pubitemid 32127779)
16. Zahradka, P., Storie, B., and Wright, B. (2009) IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II. Can. J. Physiol. Pharmacol. 87, 805-812.
17. Hua, H., Munk, S., and Whiteside, C.I. (2003) Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am. J. Physiol. Renal Physiol. 284, F303-312.
18. Kanda, Y., Mizuno, K., Kuroki, Y., and Watanabe, Y. (2001) Thrombin-induced p38 mitogen-activated protein kinase activation is mediated by epidermal growth factor receptor transactivation pathway. Br. J. Pharmacol. 132, 1657-1664. (Pubitemid 32397957)
19. Vacca, F., Bagnato, A., Catt, K.J., and Tecce, R. (2000) Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Res. 60, 5310-5317.
20. Takahashi, M. (2006) The role of endothelin-1 in vascular remodeling in vivo. Cardiovasc. Res. 71, 4-5.
21. Heagerty, A., Aalkjaer, C., Bund, S., Korsgard, N., and Mulvany, M. (1993) Small artery structure in hypertension. Hypertension 21, 391-397.
22. Viero, C., Shibuya, I., Kitamura, N., Verkhratsky, A., Fujihara, H., Katoh, A., Ueta, Y., Zingg, H.H., Chvatal, A., Sykova, E., and Dayanithi, G. (2010) REVIEW: Oxytocin: crossing the bridge between basic science and pharmacotherapy. CNS Neurosci. Ther. 16, e138-156.
23. Feng, P.H., Hsiung, T.C., Kuo, H.P., and Huang, C.D. (2010) Cross-talk between bradykinin and epidermal growth factor in regulating IL-6 production in human airway smooth muscle cells. Chang Gung Med. J. 33, 92-99.
24. Yan, Y., Shirakabe, K., and Werb, Z. (2002) The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158, 221-226.
25. Frank, G.D. and Eguchi, S. (2003) Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II. Antioxid. Redox Signal. 5, 771-780. (Pubitemid 37462060)
26. Derynck, R. and Zhang, Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584. (Pubitemid 37280136)
27. Massague, J. (2003) Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev. 17, 2993-2997.
28. Burch, M.L., Ballinger, M.L., Yang, S.N., Getachew, R., Itman, C., Loveland, K., Osman, N., and Little, P.J. (2010) Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptor. J. Biol. Chem. 285, 26798-26805.
29. Little, P.J., Burch, M.L., Getachew, R., Al-aryahi, S., and Osman, N. (2010) Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor. J. Cardiovasc. Pharmacol. 56, 360-368.
30. Inman, G.J., Nicolas, F.J., Callahan, J.F., Harling, J.D., Gaster, L.M., Reith, A.D., Laping, N.J., and Hill, C.S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62, 65-74. (Pubitemid 34680517)
31. Sorescu, D. (2006) Smad3 mediates angiotensin II- and TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot. Circ. Res. 98, 988-989.
32. Leask, A. (2010) Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 106, 1675-1680.
33. Xu, M.Y., Porte, J., Knox, A.J., Weinreb, P.H., Maher, T.M., Violette, S.M., McAnulty, R.J., Sheppard, D., and Jenkins, G. (2009) Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am. J. Pathol. 174, 1264-1279.
34. Jenkins, R.G., Su, X., Su, G., Scotton, C.J., Camerer, E., Laurent, G.J., Davis, G.E., Chambers, R.C., Matthay, M.A., and Sheppard, D. (2006) Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J. Clin. Invest. 116, 1606-1614.
35. Berry, C., Touyz, R., Dominiczak, A.F., Webb, R.C., and Johns, D.G. (2001) Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am. J. Physiol. Heart Circ. Physiol. 281, H2337-2365.
36. Wetzker, R. and Bohmer, F.D. (2003) Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat. Rev. Mol. Cell Biol. 4, 651-657. (Pubitemid 36934967)
37. Cutroneo, K.R. (2007) TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring. Wound Repair Regen. 15(Suppl 1), S54-60.
38. Ruiz-Ortega, M., Rodriguez-Vita, J., Sanchez-Lopez, E., Carvajal, G., and Egido, J. (2007) TGF-beta signaling in vascular fibrosis. Cardiovasc. Res. 74, 196-206.
39. Nigro, J., Dilley, R.J., and Little, P.J. (2002) Differential effects of gemfibrozil on migration, proliferation and proteoglycan production in human vascular smooth muscle cells. Atherosclerosis 162, 119-129. (Pubitemid 34327349)
40. Tannock, L., Little, P.J., Wight, T.N., and Chait, A. (2002) Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced binding to LDL. J. Lipid Res. 43, 149-157. (Pubitemid 34117229)
41. Little, P.J., Osman, N., and O'Brien, K.D. (2008) Hyperelongated biglycan: the surreptitious initiator of atherosclerosis. Curr. Opin. Lipidol. 19, 448-454.
42. Gustafsson, M., Levin, M., Skalen, K., Perman, J., Friden, V., Jirholt, P., Olofsson, S.O., Fazio, S., Linton, M.F., Semenkovich, C.F., Olivecrona, G., and Boren, J. (2007) Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase. Circ. Res. 101, 777-783. (Pubitemid 350287192)
43. Shah, B.H. and Catt, K.J. (2004) GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences. Trends Neurosci. 27, 48-53. (Pubitemid 38036978)